lenalidomide,rituximab,bendamustine,bortezomib
takeda,teva
['bet', 'lymsm']
. asks why there is such a difference between this study and the european mcl network study of len maintenance: is it due to benda-related t-cell impairment? #ash22 #lymsm
haematology registrar | fellow @PORTAL_research @harvardmed |
evidence-based medicine | health policy | lymphoma | myeloma |
Fulbright scholar | muso | writer